Engineering for new heights in the treatment of Inflammatory Bowel Disease
Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches with the goal of creating Inflammatory Bowel Disease (IBD) therapies with uncompromising efficacy and convenience.
ABOUT US
Spyre is on a mission to improve treatment options for IBD. Our team has deep experience developing and commercializing treatments across a broad range of diseases, and is committed to helping patients living with IBD.
OUR APPROACH
We are dedicated to researching potential improvements in efficacy and dosing through our investigational next-generation antibodies and rational combinations. Together with precision immunology approaches, we aspire to provide patients promising new treatment options.
Join Us
We believe that collaboration drives innovation. At Spyre, we are cultivating an environment fueled by our shared passion for combating IBD and our goal to achieve better outcomes for patients.
